Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

SPRYSPRY
Showing 8 of 21 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in ARS PHARMACEUTICALS INC

RA CAPITAL MANAGEMENT, L.P. holds 10.9M shares of SPRY (ARS PHARMACEUTICALS INC), worth $87M as of 2026-Q2. SPRY represents 0.8% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$87M

Current Shares

10.9M

Total Value Change

-$70.5M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
10.9M
0.0%
$87M0.8%$8.01
0
2026-Q1
Unchanged
10.9M
0.0%
$87.2M0.9%$8.87
0
2025-Q4
Unchanged
10.9M
0.0%
$126.5M1.3%$11.64
0
2025-Q3
Unchanged
10.9M
0.0%
$109.2M1.3%$9.72
0
2025-Q2
Unchanged
10.9M
0.0%
$189.5M3.2%$18.20
0
2025-Q1
Unchanged
10.9M
0.0%
$136.6M2.3%$12.49
0
2024-Q4
Unchanged
10.9M
0.0%
$114.6M1.5%$10.62
0
2024-Q3
Unchanged
10.9M
0.0%
$157.5M1.8%$14.32
0

Other major holders of SPRY: BlackRock, Inc., ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used